Comprehensive 3DCRT Hypofractionated Radiotherapy Schedule for Localized Prostate Adenocarcinoma in the Era of IMRT: Dosimetric and Endoscopic Analysis

被引:0
|
作者
Kougioumtzopoulou, Andromachi [1 ]
Syrigos, Nick [2 ]
Zygogianni, Anna [3 ]
Georgakopoulos, Ioannis [3 ]
Platoni, Kalliopi [1 ]
Patatoukas, George [1 ]
Tzannis, Kimon [4 ]
Bamias, Aristotelis [4 ]
Kelekis, Nikolaos [1 ]
Kouloulias, Vasileios [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, ATTIKON Univ Hosp, Med Sch, Dept Radiol 2,Radiotherapy Unit, Athens 12462, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 3, Oncol Unit, Athens 12462, Greece
[3] Natl & Kapodistrian Univ Athens, Med Sch, Dept Radiol 1, Radiotherapy Unit, Athens 12462, Greece
[4] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Propaedeut Dept Internal Med 2, Chaidari 12462, Greece
关键词
moderate hypofractionated radiotherapy; prostate cancer; intensity-modulated radiation therapy (IMRT); three-dimensional conformal radiation therapy (3DCRT); dosimetry; rectoscopy; rectal wall; Vienna Rectoscopy Score (VRS); dose volume histogram (DVH); LATE RECTAL TOXICITY; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; FRACTIONATION SCHEDULES; CONFORMAL RADIOTHERAPY; RANDOMIZED-TRIAL; MUCOSAL CHANGES; CANCER; RISK; PROCTOSCOPY;
D O I
10.3390/cancers16061192
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Moderate hypofractionated radiotherapy (MHRT) has emerged as the preferred treatment modality for localized prostate cancer. The aim of this prospective study was to evaluate late rectal toxicity while performing a comprehensive dosimetric analysis in conjunction with rectoscopy results in the setting of MHRT. We confirmed in an homogeneous population (20 patients) that when 3DCRT is employed, delineation of rectal wall and its subsegments can provide a more in depth accurate dosimetric analysis. Furthermore, we identified that dose endpoints V52.17Gy and V56.52Gy, when hypofractionated schedule (2.75 Gy per fraction) is used, may have a significant impact on rectal mucosal injury. Implementing these variables in clinical practice may result in a decrease rate of late rectal toxicity; more data is needed to assist in further validation of this conclusion.Abstract Background: Moderate hypofractionated radiotherapy (MHRT) has emerged as the preferred treatment modality for localized prostate cancer based on randomized controlled studies regarding efficacy and toxicity using contemporary radiotherapy techniques. In the setting of MHRT, available data on dosimetric parameters and late rectal toxicity are limited. Aim: To present the effects of MHRT on late rectal toxicity while conducting an extensive dosimetric analysis in conjunction with rectoscopy results. Methods: This is a prospective study including patients with intermediate-risk prostate adenocarcinoma. All patients were treated with MHRT 44 Gy in 16 fractions to the seminal vesicles and to the prostate, followed by a sequential boost to the prostate alone of 16.5 Gy in 6 fractions delivered with three-dimensional conformal radiation therapy (3DCRT). Acute and late toxicity were assessed. Endoscopy was performed at baseline, every 3 months post-therapy for the first year, and every 6 months for the year after. The Vienna Rectoscopy Score (VRS) was used to assess rectal mucosal injury related to radiotherapy. Dosimetric analysis for the rectum, rectal wall, and its subsegments (upper, mid, and low 1/3) was performed. Results: Between September 2015 and December 2019, 20 patients enrolled. Grade 1 late gastrointestinal toxicity occurred in 10% of the patients, whereas 5% had a grade >= 2. Twelve months post radiotherapy: 4 (20%) patients had VRS 1; 2 (10%) patients had VRS 2; 1(5%) patient had VRS 3. 24 months post radiotherapy, VRS 1 was observed in 4 patients (20%) and VRS 2 in 3 (15%) patients. The dosimetric analysis demonstrated noticeable variations between the rectum, rectal wall, and rectal wall subsegments. The dosimetric analysis of the rectum, rectal wall, and its mid and low segments with respect to rectoscopy findings showed that the higher dose endpoints V52.17Gy and V56.52Gy are associated with rectal mucosal injury. Conclusions: A thorough delineation of the rectal wall and its subsegments, together with the dosimetric analysis of these structures, may reduce late rectal toxicity. Dosimetric parameters such as V52.17Gy and V56.52Gy were identified to have a significant impact on rectal mucosal injury; additional dose endpoint validation and its relation to late GI toxicity is needed.
引用
收藏
页数:20
相关论文
共 44 条
  • [31] Dosimetric plan evaluation of hypofractionated 3-dimensional conformal radiotherapy (3DCRT) and 2-dimensional (2D) simulator planning in whole breast irradiation after breast conserving surgery
    Roy, M.
    Goswami, B.
    Goswami, S.
    Jadhav, A.
    Agarwal, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate
    Bansal, A.
    Kapoor, R.
    Singh, S. K.
    Kumar, N.
    Oinam, A. S.
    Sharma, S. C.
    INDIAN JOURNAL OF UROLOGY, 2012, 28 (03) : 300 - 306
  • [33] Hypofractionated radiotherapy for localized prostate cancer using three-dimensional conformal radiotherapy technique: 3 years toxicity analysis
    White, R.
    Woolf, D.
    Li, S.
    Alonzi, R.
    Osler, P.
    Hoskin, P.
    Hughes, R.
    INDIAN JOURNAL OF CANCER, 2015, 52 (04) : 654 - 657
  • [34] Association of radiation and tissue homeostasis response gene polymorphisms with clinical late toxicity in patients treated with three-dimensional conformal radiotherapy (3DCRT) for adenocarcinoma of the prostate
    Parliament, M
    Damaraju, S
    Murray, D
    Dufour, J
    Myrehaug, S
    Anderson, S
    Fallone, G
    Field, C
    Greiner, R
    Menard, C
    Hanson, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S25 - S25
  • [35] Single nucleotide polymorphisms in radiation response genes correlate with clinical late toxicity in patients treated with three-dimensional conformal radiotherapy (3DCRT) for adenocarcinoma of the prostate
    Parliament, M
    Damaraju, S
    Murray, D
    Dufour, J
    Myrehaug, S
    Greiner, W
    Fallone, G
    Field, C
    Menard, C
    Hanson, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S23 - S23
  • [36] Effects of the Irradiation Technique (IMRT / VMAT vs. 3DcRT) on Therapy-Associated Side-Effects in the curative intended Percutaneous Radiotherapy of Prostate Cancer: Data from a Retrospective Center Analysis
    Guhlich, M.
    Droege, L. H.
    Leu, M.
    Rave-Frank, M.
    Hess, C. -F
    Wolff, H. A.
    Hille, A.
    Schirmer, M. A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S136 - S136
  • [37] A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed
    Carter, Hannah E.
    Martin, Andrew
    Schofield, Deborah
    Duchesne, Gillian
    Haworth, Annette
    Hornby, Colin
    Sidhom, Mark
    Jackson, Michael
    RADIOTHERAPY AND ONCOLOGY, 2014, 112 (02) : 187 - 193
  • [38] Dosimetric Comparison of Three-Dimensional Conformal Radiotherapy (3DCRT) and Volumetric Modulated Arc Therapy (VMAT) Plans for Hypofractionated Whole Breast and Regional Nodes Irradiation in Breast Cancer Patients Following Breast Conservative Surgery
    Khosla, D.
    Kapoor, R.
    Rana, S.
    Tomar, P.
    Periasamy, K.
    Madan, R.
    Goyal, S.
    Kumar, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E321 - E321
  • [39] A comprehensive clinical 3-dimensional dosimetric analysis of forward planned IMRT and conventional wedge planned techniques for intact breast radiotherapy
    Herrick, Joseph S.
    Neill, Cory J.
    Rosser, Peter F.
    MEDICAL DOSIMETRY, 2008, 33 (01) : 62 - 70
  • [40] Phase III Randomized Trial of Postoperative Adjuvant Conventional Radiation (3DCRT) versus Image Guided Intensity Modulated Radiotherapy (IG-IMRT) in Cervical Cancer (PARCER): Final Analysis
    Chopra, S.
    Dora, T.
    Gupta, S.
    Kannan, S.
    Engineer, R.
    Menachery, S.
    Phurailatpam, R.
    Mahantshetty, U. M.
    Swamidas, J.
    Ghosh, J.
    Maheshwari, A.
    Ts, S.
    Kerkar, R.
    Deodhar, K.
    Popat, P.
    Shrivastava, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S1 - S2